Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History SYBX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics SYBX

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Synlogic Inc

SYBX
Current price
1.18 USD -0.02 USD (-1.67%)
Last closed 1.20 USD
ISIN US87166L1008
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 13 801 397 USD
Yield for 12 month -18.75 %
1Y
3Y
5Y
10Y
15Y
SYBX
21.11.2021 - 28.11.2021

Synlogic, Inc., a biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic diseases in the United States. Its pipeline include SYNB1618 for the treatment of phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed drug candidate, which is in Phase I clinical to treat homocystinuria; SYNB8802, an orally administered, non-systemically absorbed drug candidate for the treatment of enteric hyperoxaluria; and SYNB2081 to lower uric acid for the potential treatment of gout. The company has a collaboration agreement with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; and Ginkgo Bioworks, Inc. Synlogic, Inc. is based in Winchester, Massachusetts. Address: PO Box 30, Winchester, MA, United States, 01890

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

1.00 USD

P/E Ratio

5.36

Dividend Yield

Financials SYBX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures SYBX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+8 000 USD

Last Year

+3 371 000 USD

Current Quarter

Last Quarter

Current Year

+8 000 USD

Last Year

+3 371 000 USD

Current Quarter

Last Quarter

EBITDA -5 992 250 USD
Operating Margin TTM
Price to Earnings 5.36
Return On Assets TTM -14.07 %
PEG Ratio
Return On Equity TTM 19.41 %
Wall Street Target Price 1.00 USD
Revenue TTM
Book Value 1.12 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -100.00 %
Dividend Yield
Gross Profit TTM
Earnings per share 0.22 USD
Diluted Eps TTM 0.22 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation SYBX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 5.36
Forward PE
Enterprise Value Revenue 0.35
Price Sales TTM 1 652.07
Enterprise Value EBITDA 0.18
Price Book MRQ 1.05

Technical Indicators SYBX

For 52 Weeks

0.90 USD 1.88 USD
50 Day MA 1.18 USD
Shares Short Prior Month 37 913
200 Day MA 1.32 USD
Short Ratio 3.80
Shares Short 38 981
Short Percent 0.73 %